Free Trial
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Prestige Consumer Healthcare logo
$75.70 +0.57 (+0.76%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$75.78 +0.08 (+0.11%)
As of 07/18/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Key Stats

Today's Range
$74.75
$76.32
50-Day Range
$75.08
$89.24
52-Week Range
$64.94
$90.04
Volume
419,148 shs
Average Volume
316,403 shs
Market Capitalization
$3.74 billion
P/E Ratio
17.65
Dividend Yield
N/A
Price Target
$93.33
Consensus Rating
Moderate Buy

Company Overview

Prestige Consumer Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

PBH MarketRank™: 

Prestige Consumer Healthcare scored higher than 80% of companies evaluated by MarketBeat, and ranked 218th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prestige Consumer Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Prestige Consumer Healthcare has only been the subject of 1 research reports in the past 90 days.

  • Read more about Prestige Consumer Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Prestige Consumer Healthcare are expected to grow by 5.78% in the coming year, from $4.50 to $4.76 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prestige Consumer Healthcare is 17.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.49.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prestige Consumer Healthcare is 17.65, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.01.

  • Price to Earnings Growth Ratio

    Prestige Consumer Healthcare has a PEG Ratio of 2.25. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Prestige Consumer Healthcare has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prestige Consumer Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    3.42% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

  • Dividend Yield

    Prestige Consumer Healthcare does not currently pay a dividend.

  • Dividend Growth

    Prestige Consumer Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.42% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 4.4.
  • Change versus previous month

  • News Sentiment

    Prestige Consumer Healthcare has a news sentiment score of 1.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Prestige Consumer Healthcare this week, compared to 5 articles on an average week.
  • Search Interest

    1 people have searched for PBH on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Prestige Consumer Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.40% of the stock of Prestige Consumer Healthcare is held by insiders.

  • Percentage Held by Institutions

    99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Prestige Consumer Healthcare's insider trading history.
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

PBH Stock Analysis - Frequently Asked Questions

Prestige Consumer Healthcare's stock was trading at $78.09 at the beginning of 2025. Since then, PBH shares have decreased by 3.1% and is now trading at $75.70.

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its earnings results on Thursday, May, 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year.
Read the conference call transcript
.

Prestige Consumer Healthcare's top institutional shareholders include Congress Asset Management Co. (2.04%), Wedge Capital Management L L P NC (0.08%), State of Alaska Department of Revenue (0.06%) and Robbins Farley (0.06%). Insiders that own company stock include Ronald M Lombardi, William P'pool, Adel Mekhail and Mary Beth Fritz.
View institutional ownership trends
.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/08/2025
Today
7/19/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Personal Products
Current Symbol
NYSE:PBH
CIK
1295947
Employees
540
Year Founded
N/A

Price Target and Rating

High Price Target
$104.00
Low Price Target
$76.00
Potential Upside/Downside
+23.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.29
Trailing P/E Ratio
17.65
Forward P/E Ratio
16.82
P/E Growth
2.25
Net Income
$214.60 million
Net Margins
18.86%
Pretax Margin
24.98%
Return on Equity
12.87%
Return on Assets
6.78%

Debt

Debt-to-Equity Ratio
0.55
Current Ratio
4.20
Quick Ratio
2.82

Sales & Book Value

Annual Sales
$1.14 billion
Price / Sales
3.29
Cash Flow
$5.25 per share
Price / Cash Flow
14.41
Book Value
$37.04 per share
Price / Book
2.04

Miscellaneous

Outstanding Shares
49,420,000
Free Float
48,723,000
Market Cap
$3.74 billion
Optionable
Optionable
Beta
0.43

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:PBH) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners